ABOUT THE DMMC

Please note this site is maintained as an archive of DMMC activities. DMMC became Molecular Medicine Ireland on 17 April 2008
Please visit the Molecular Medicine Ireland website for information on current activities

The Dublin Molecular Medicine Centre (DMMC) is a not for profit company being established Royal College of Surgeons in Ireland, Trinity College Dublin and University College Dublin to achieve their common objectives in accelerating the translation of scientific research into better quality outcomes for patients.

The Dublin Molecular Medicine Centre (DMMC) was established through the Higher Education Authority's Programme for Research in Third Level Institutions, in partnership with Atlantic Philanthropies, as part of the National Development Plan.

DMMC represents a highly focused research partnership in the life sciences between Royal College of Surgeons in Ireland (RCSI), Trinity College Dublin (TCD) and University College Dublin (UCD). A network of affiliated hospitals provides the setting for accelerated translational bioscience.

DMMC is harnessing the results of the Human Genome Project to increase understanding of the pathogenesis and treatment of common acquired diseases. The co-ordinated application of genomics and proteomics is being employed to identify novel therapeutic targets and their modulators in our primary areas of research focus:

• Cancer Biology.
• Infection, Inflammation and Immunity.
• Neuroscience.
• Vascular Biology.
  

DMMC is actively:

• Integrating and synergising expertise in molecular medicine research to position Dublin as a state-of-the-art, internationally competitive and sustainable centre of excellence.
• Adding value in research at Ireland's premier academic institutions by developing core technology platforms, establishing a critical mass of biomedical research and by attracting & developing quality graduates, who will fuel the future development of Irish bioindustry.
• Forging a new and dynamic research partnership that serves Ireland's broader social, economic and health needs into the future.
• Enriching the nation's research and educational milieu and creating new knowledge that enhances Ireland's position in the fields of science and technology.
• Placing Ireland's molecular medicine research programme in the appropriate ethical and societal context